(PFE) - Analyzing Pfizer's Short Interest
Portfolio Pulse from Benzinga Insights
Pfizer's short interest has decreased by 9.85%, with 67.62 million shares sold short, representing 1.19% of its float. This is lower than the peer group average of 4.54%. The decrease in short interest may indicate a more bullish sentiment towards Pfizer.
October 11, 2024 | 1:30 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Pfizer's short interest has decreased by 9.85%, with 67.62 million shares sold short, representing 1.19% of its float. This is lower than the peer group average of 4.54%. The decrease in short interest may indicate a more bullish sentiment towards Pfizer.
The decrease in short interest suggests that fewer investors are betting against Pfizer, which could indicate a shift towards a more positive market sentiment. This is further supported by the fact that Pfizer's short interest is significantly lower than its peers, potentially making it more attractive to investors.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100